A hypoxic inducible factor-1α hybrid enhances collateral development and reduces vascular leakage in diabetic rats

Genzyme Corporation, Framingham, MA 01701-9322, USA.
The Journal of Gene Medicine (Impact Factor: 2.47). 05/2009; 11(5):390-400. DOI: 10.1002/jgm.1318
Source: PubMed


Diabetes mellitus is a common comorbidity of atherosclerosis. Hypoxia-inducible factor-1 (HIF-1) is the master regulator of the angiogenic response to hypoxia.
We studied the effects of adenoviral vectors expressing a constitutively active HIF-1 alpha hybrid (Ad2/HIF-1 alpha/VP16) or vascular endothelial growth factor (Ad2/VEGF) on collateral development and vascular leakiness in a diabetic rat model of hindlimb ischemia.
After the removal of the right femoral artery, the mRNA levels of VEGF, angiopoietin-1 and angiopietin-4 in the calf muscles, as measured by Taqman reverse transcriptase-polymerase chain reaction, were transiently elevated in Zucker lean (ZL) but not Zucker diabetic fatty (ZDF) rats. The angiographic score, as determined by post-mortem angiography, was significantly lower in ZDF animals 35 days after surgery compared to their ZL counterparts. In separate animals, intramuscular injection of Ad2/HIF-1a/VP16 and Ad/2VEGF into the thigh muscles significantly increased the angiographic score and capillary density 21 and 35 days after the injection compared to Ad2/CMVEV (a vector expressing no transgene) or vehicle. After the injection of Ad2/CMVEV or vehicle, the Evans-blue dye content in the thigh muscles was significantly higher in ZDF rats than their ZL counterparts. Ad2/HIF-1 alpha/VP16 but not Ad2/VEGF reduced tissue Evans blue dye content.
The endogenous angiogenic response to ischemia was impaired in ZDF rats, possibly due to down-regulation of angiogenic factors. Ad2/HIF-1 alpha/VP16 enhanced collateral development and reduced vascular leakage in the ischemic hindlimb of ZDF rats indicating that hybrid HIF-1 alpha angiogenic therapy may be efficacious for peripheral vascular disease with a diabetic comorbidity.

1 Follower
38 Reads
  • Source
    • "Similar approaches with hybrid HIF1α/VP16 have been used in rabbit and diabetic rat models of limb ischemia and have even progressed through Phase I and II clinical studies in patients with severe peripheral arterial disease (Vincent et al., 2000; Rajagopalan et al., 2007; Kajiwara et al., 2009). These interventions have also been applied to other ischemic injuries such as wound healing and myocardial infarction (Liu et al., 2008; Mace et al., 2007; Heinl-Green et al., 2005). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Oxygen (O(2)) is an essential nutrient that serves as a key substrate in cellular metabolism and bioenergetics. In a variety of physiological and pathological states, organisms encounter insufficient O(2) availability, or hypoxia. In order to cope with this stress, evolutionarily conserved responses are engaged. In mammals, the primary transcriptional response to hypoxic stress is mediated by the hypoxia-inducible factors (HIFs). While canonically regulated by prolyl hydroxylase domain-containing enzymes (PHDs), the HIFα subunits are intricately responsive to numerous other factors, including factor-inhibiting HIF1α (FIH1), sirtuins, and metabolites. These transcription factors function in normal tissue homeostasis and impinge on critical aspects of disease progression and recovery. Insights from basic HIF biology are being translated into pharmaceuticals targeting the HIF pathway.
    Preview · Article · Oct 2010 · Molecular cell
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: This paper presents some case studies of multi-frequency multi-polarization brightness temperatures obtained in a variety of surface and atmospheric conditions. All of the channels showed the characteristic sinusoidal modulation with azimuth caused by wind stress on the ocean surface. The lowest frequency channel (10 GHz) seemed to show more modulation than other frequencies, especially in the U channel. The U channel was the least sensitive to the atmospheric conditions
    Preview · Conference Paper · Aug 1998
  • [Show abstract] [Hide abstract]
    ABSTRACT: Diabetes and its complications are a major public health burden in the developed world. The major cause of diabetic complications is abnormal growth of new blood vessels. This dysfunctional neovascularization results in significant morbidity and mortality in patients with diabetes and, as such, is a major focus of basic and clinical investigation. It has become clear that hyperglycemia disrupts tissue-level signaling in response to hypoxia and ischemia, impairs the vasculogenic potential of circulating stem cells and fundamentally alters the structure and function of key neovascularization proteins, including hypoxia-inducible factor-1. These mechanistic and pathophysiologic studies have revealed new therapeutic targets to restore normal neovascularization and to ameliorate and prevent diabetic vascular complications.
    No preview · Article · Dec 2009 · Expert Review of Endocrinology & Metabolism
Show more